1. Home
  2. OM vs KRON Comparison

OM vs KRON Comparison

Compare OM & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OM
  • KRON
  • Stock Information
  • Founded
  • OM 2003
  • KRON 2017
  • Country
  • OM United States
  • KRON United States
  • Employees
  • OM N/A
  • KRON N/A
  • Industry
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KRON Medicinal Chemicals and Botanical Products
  • Sector
  • OM Health Care
  • KRON Health Care
  • Exchange
  • OM Nasdaq
  • KRON Nasdaq
  • Market Cap
  • OM 50.5M
  • KRON 54.4M
  • IPO Year
  • OM 2020
  • KRON 2020
  • Fundamental
  • Price
  • OM $15.30
  • KRON $0.72
  • Analyst Decision
  • OM Buy
  • KRON Buy
  • Analyst Count
  • OM 2
  • KRON 3
  • Target Price
  • OM $29.50
  • KRON $1.63
  • AVG Volume (30 Days)
  • OM 157.4K
  • KRON 796.1K
  • Earning Date
  • OM 05-07-2025
  • KRON 05-20-2025
  • Dividend Yield
  • OM N/A
  • KRON N/A
  • EPS Growth
  • OM N/A
  • KRON N/A
  • EPS
  • OM N/A
  • KRON N/A
  • Revenue
  • OM $115,273,000.00
  • KRON $9,192,000.00
  • Revenue This Year
  • OM $8.98
  • KRON N/A
  • Revenue Next Year
  • OM $12.74
  • KRON N/A
  • P/E Ratio
  • OM N/A
  • KRON N/A
  • Revenue Growth
  • OM N/A
  • KRON 56.62
  • 52 Week Low
  • OM $5.85
  • KRON $0.67
  • 52 Week High
  • OM $78.30
  • KRON $1.60
  • Technical
  • Relative Strength Index (RSI)
  • OM 67.56
  • KRON 35.81
  • Support Level
  • OM $11.19
  • KRON $0.67
  • Resistance Level
  • OM $12.79
  • KRON $0.76
  • Average True Range (ATR)
  • OM 1.22
  • KRON 0.05
  • MACD
  • OM 0.44
  • KRON -0.01
  • Stochastic Oscillator
  • OM 79.36
  • KRON 19.69

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

About KRON Kronos Bio Inc.

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Share on Social Networks: